Page last updated: 2024-08-26

2,3-bis(4-hydroxyphenyl)-propionitrile and Debility

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Debility in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bukovac, S; Green, MR; Guerin, C; Isedowo, R; Lillie, L; McCormick, CM; Nar, NN; Said, SA; Simone, JJ; Stuart, JA1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Debility

ArticleYear
Effects of long-term dietary administration of estrogen receptor-beta agonist diarylpropionitrile on ovariectomized female ICR (CD-1) mice.
    GeroScience, 2018, Volume: 40, Issue:4

    Topics: Aging; Animals; Behavior, Animal; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogen Receptor beta; Female; Frailty; Mice; Mice, Inbred ICR; Nitriles; Ovariectomy; Propionates; Random Allocation; Reference Values

2018